Page last updated: 2024-09-03

1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene and mdl 27048

1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene has been researched along with mdl 27048 in 1 studies

Compound Research Comparison

Studies
(1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene)
Trials
(1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene)
Recent Studies (post-2010)
(1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene)
Studies
(mdl 27048)
Trials
(mdl 27048)
Recent Studies (post-2010) (mdl 27048)
11021002

Protein Interaction Comparison

ProteinTaxonomy1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene (IC50)mdl 27048 (IC50)
Tubulin alpha-1A chainSus scrofa (pig)0.012
Tubulin beta-1 chainHomo sapiens (human)10

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ducki, S; Lawrence, NJ; Mackenzie, G; Snyder, JP1

Other Studies

1 other study(ies) available for 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene and mdl 27048

ArticleYear
Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly.
    Journal of medicinal chemistry, 2005, Jan-27, Volume: 48, Issue:2

    Topics: Antineoplastic Agents; Bibenzyls; Binding Sites; Colchicine; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Stilbenes; Tubulin; Tubulin Modulators

2005